Prognostic value of pan-immune-inflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study

Authors:
  • PDPiotr Domański
    Piotr Domański
  • JJJadwiga Jarosińska
    Jadwiga Jarosińska
  • BKBarbara Kruczyk
    Barbara Kruczyk
  • MPMateusz Piętak
    Mateusz Piętak
  • AMAnna Mydlak
    Anna Mydlak
  • TDTomasz Demkow
    Tomasz Demkow
  • ŁKŁukasz Kuncman
    Łukasz Kuncman
  • MDMarta Darewicz
    Marta Darewicz
  • BSBożena Sikora-Kupis
    Bożena Sikora-Kupis
  • WMWojciech Michalski
    Wojciech Michalski

Abstract
Introduction: Geriatric patients with metastatic renal cell carcinoma (mRCC) are underrepresented in clinical trials. Evaluation of the efficacy of the treatment and assignation of individuals to proper prognostic groups is an absolute necessity to guarantee them the best possible care....

This publication has 42 references indexed in Scilit: